Works matching IS 14642662 AND DT 2012 AND VI 13 AND IP 7

Results: 10

Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE Effect of gender and race on the week 48 findings in treatment-naïve,...

Published in:

2012

By:

Hodder, S;
Arasteh, K;
De Wet, J;
Gathe, J;
Gold, J;
Kumar, P;
Mohapi, L;
Short, W;
Crauwels, H;
Vanveggel, S;
Boven, K

Publication type:

Journal Article

Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE

Published in:

HIV Medicine, 2012, v. 13, n. 7, p. 406, doi. 10.1111/j.1468-1293.2012.00991.x

By:

Hodder, S;
Arasteh, K;
De Wet, J;
Gathe, J;
Gold, J;
Kumar, P;
Mohapi, L;
Short, W;
Crauwels, H;
Vanveggel, S;
Boven, K

Publication type:

Article

Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians.

Published in:

HIV Medicine, 2012, v. 13, n. 7, p. 387, doi. 10.1111/j.1468-1293.2011.00984.x

By:

Huber, M;
Ledergerber, B;
Sauter, R;
Young, J;
Fehr, J;
Cusini, A;
Battegay, M;
Calmy, A;
Orasch, C;
Nicca, D;
Bernasconi, E;
Jaccard, R;
Held, L;
Weber, R

Publication type:

Article

No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients.

Published in:

HIV Medicine, 2012, v. 13, n. 7, p. 448, doi. 10.1111/j.1468-1293.2012.00995.x

By:

Welzen, BJ;
Mudrikova, T;
Arends, JE;
Hoepelman, AIM

Publication type:

Article

The Recent Infection Testing Algorithm ( RITA) in clinical practice: a survey of HIV clinicians in England and Northern Ireland.

Published in:

HIV Medicine, 2012, v. 13, n. 7, p. 444, doi. 10.1111/j.1468-1293.2012.00990.x

By:

Garrett, NJ;
Lattimore, S;
Gilbart, VL;
Aghaizu, A;
Mensah, G;
Tosswill, J;
Murphy, G;
Delpech, V

Publication type:

Article

Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest

Published in:

HIV Medicine, 2012, v. 13, n. 7, p. 427, doi. 10.1111/j.1468-1293.2012.00994.x

By:

Girard, P-M;
Campbell, TB;
Grinsztejn, B;
Hartikainen, J;
Rachline, A;
Nijs, S;
Witek, J

Publication type:

Article

An analysis of patients' understanding of 'routine' preoperative blood tests and HIV screening. Is no news really good news?

Published in:

HIV Medicine, 2012, v. 13, n. 7, p. 439, doi. 10.1111/j.1468-1293.2012.00993.x

By:

Albrecht, E;
Frascarolo, P;
Meystre-Agustoni, G;
Farron, A;
Gilliard, N;
Darling, KEA;
Cavassini, M

Publication type:

Article

Nonoccupational post-exposure prophylaxis source tracing: is it really feasible in Australia?

Published in:

HIV Medicine, 2012, v. 13, n. 7, p. 436, doi. 10.1111/j.1468-1293.2011.00986.x

By:

Pierce, AB;
Armishaw, J;
Price, B;
Wright, EJ;
Dax, EM;
Fairley, CK;
Hoy, JF

Publication type:

Article

HIV testing in community settings in resource-rich countries: a systematic review of the evidence.

Published in:

HIV Medicine, 2012, v. 13, n. 7, p. 416, doi. 10.1111/j.1468-1293.2012.00992.x

By:

Thornton, AC;
Delpech, V;
Kall, MM;
Nardone, A

Publication type:

Article

The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir ( DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/ mL at baseline.

Published in:

HIV Medicine, 2012, v. 13, n. 7, p. 398, doi. 10.1111/j.1468-1293.2012.00989.x

By:

Arribas, JR;
Clumeck, N;
Nelson, M;
Hill, A;
Delft, Y;
Moecklinghoff, C

Publication type:

Article